Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- What will be covered in the talk
- What will not be covered in the talk
- Historic definition of status epilepticus (1876)
- Older definitions of status epilepticus (1900's)
- Evolution of status epilepticus definition
- Generalized tonic/clonic seizure phases-duration
- Duration of the ictal phase
- Duration of most seizures
- Proposed operational definition of SE
- Proposed mechanistic definition of SE
- Epidemiology/outcome
- Outcome of SE by etiology (1)
- Outcome of SE by etiology (2)
- Risk factors for mortality
- Mechanisms
- SE related to factors that maintain\stop seizures
- Seizure duration and Diazepam effective doses
- Seizure duration and GABA(A)-R modulation
- Ionic channel structure\function modulated in SE
- Do seizure suppression mechanisms fail in SE?
- Treatment
- Initial management of SE
- Treatment of SE circa 1990
- Treatment of SE circa 2010
- Four drug regimens compared for SE treatment
- VA cooperative trial - main results
- Sequential responses to treatment
- Treating patients in RSE
- Treatment response and outcomes in RSE (1)
- Treatment response and outcomes in RSE (2)
- Treatment response and outcomes in RSE (3)
- Using Topiramate in RSE
- Using inhalational anesthetic drugs in RSE
- Using IV Levetiracetam in RSE
- RSE - treatment recommendation
- RSE treatment endpoint
- Pre-hospital therapy
- Pre-hospital treatment of SE
- PHTSE - study design
- PHTSE - final results
- PHTSE - patient disposition
- PHTSE - main questions answered
- IM Midazolam vs. IV Lorazepam
- NETT network
- RAMPART - study design
- RAMPART - autoinjectors and drug dosage
- Take home messages
Topics Covered
- Generalized status epilepticus
- Evolution of the definition of status epilepticus
- Epidemiological studies of status epilepticus
- Basic mechanisms of status epilepticus
- Treatment approaches for status epilepticus in the hospital and out-of-hospital settings
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lowenstein, D. (2011, May 3). Status epilepticus [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/PXYK7907.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Daniel Lowenstein has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.